SMARTphone-Based Cardiovascular Risk Reduction In BREAST Cancer Patients
Funder
National Health and Medical Research Council
Funding Amount
$88,662.00
Summary
Heart disease is a leading cause of death in patients with breast cancer. Physical exercise during cancer treatment has been shown to improve overall survival by reducing future problems with the heart as well as recurrence of the cancer. Despite this, few women achieve the guideline recommended target for exercise. This study will test a Smartphone application called 'BreastMate' which is designed to promote physical activity and heart health in patients with breast cancer.
Management Of Paediatric Acute Severe Behavioural Disturbance In The Emergency Department
Funder
National Health and Medical Research Council
Funding Amount
$114,376.00
Summary
Acute Severe Behavioural Disturbance (ASBD) is a medical condition where a person loses control of their behaviour and becomes extremely agitated or aggressive. It usually occurs as a result of an underlying medical problem. People who develop ASBD often come to the Emergency Department (ED) to receive care. My PhD will investigate why children develop ASBD and determine the best management for these individuals when they present to the ED.
Optimising Cooperative Group Cancer Clinical Trials In The Era Of Molecularly Targeted Treatments
Funder
National Health and Medical Research Council
Funding Amount
$55,778.00
Summary
Cancer treatments are tested in trials to ensure that they are effective and safe for use. Recently treatments have been developed that act on newly discovered pathways of cancer growth. I aim to research the way cancer clinical trials are designed and evaluate ways to improve them. This will help to ensure cancer medicines are brought into clinical use as efficiently as possible in this new era of drug treatment.
Improving The Treatment Of Neonatal Sepsis Through Vancomycin Pharmacokinetic And Pharmacodynamic Modelling
Funder
National Health and Medical Research Council
Funding Amount
$71,458.00
Summary
Our study will assess whether vancomycin, a key antibiotic used to treat severe infections in young infants, is best given as a continuous infusion or as multiple doses per day. We will determine which is the most effective method to achieve the target blood level of vancomycin and if current recommended target levels for vancomycin are appropriate for infants. Findings will be used to develop a bedside tool that will enable clinicians to tailor the dose of vancomycin to individual children.
Enhancing Communication Between Medical Oncologists And Patients With Advanced Malignancy Considering Clinical Trial Participation, With A Focus On CALD Populations
Funder
National Health and Medical Research Council
Funding Amount
$92,335.00
Summary
In the advanced stages of cancer, some patients will need to choose between multiple options - they might wish to pay for an expensive but unfunded drug, they may consider taking part in a clinical trial or opt to stay at home and focus on the time they have. This project will aim to help patients make these difficult decisions with their clinicians, and will have a focus on those from culturally and linguistically diverse backgrounds as they face additional barriers to trial entry.
Strategies To Reduce The Burden Of Gastroenteritis In Aboriginal Children.
Funder
National Health and Medical Research Council
Funding Amount
$124,676.00
Summary
Rotavirus is the leading cause of severe gastroenteritis in children. Despite early promise, vaccines which target rotavirus seem to be less effective in low-resource settings and also amongst Australian Indigenous children. This study seeks to assess whether an extra dose of rotavirus vaccine (RV1) will improve the effectiveness of rotavirus vaccine in Aboriginal children and result in decreased admissions and clinic visits in the first three years of life.
A Randomised Control Trial Evaluating Outcomes Of An Emergency Nurse Practitioner Service.
Funder
National Health and Medical Research Council
Funding Amount
$83,149.00
Summary
This proposed research will provide much needed evidence on this reform model. Health services research struggles to establish an inquiry context that is flexible to study service-level interventions using the gold standard of a randomised controlled trail (RCT). This proposed research will be conducted in a health service environment with a stable E-NP service innovation and capacity to randomise patient participants.
Domiciliary Oxygen Therapy In Interstitial Lung Disease
Funder
National Health and Medical Research Council
Funding Amount
$124,608.00
Summary
Interstitial lung diseases (ILD) are chronic lung diseases with significant health impacts, but limited drug treatment options. Although home oxygen treatment (HOT) is commonly used in these patients, its clinical benefits are uncertain with potential risks and significant costs for both patients and the health care system. Very little published information is available on the use of HOT in these patients. These studies aim to improve our knowledge and management of HOT in patients with ILD.
The Impact Of Omega-3 Fatty Acids On The Inflammatory Mediators Of Heart Disease
Funder
National Health and Medical Research Council
Funding Amount
$48,028.00
Summary
Fish oils are consumed widely for their omega-3 fatty acids, which have multiple health benefits. Despite the benefits of fish oil for cardiovascular disease seen in early studies, recent studies have not shown a protective effect. Hence, we are studying the effects of omega-3s on the development of atherosclerosis (fatty plaque build up in arteries) by investigating their role in inflammation in the blood vessel wall and in fatty tissue. This is using cells, animals and human studies
Improving The Quantity, Quality, Relevance And Conduct Of Clinical Trials Of Medicines In Children.
Funder
National Health and Medical Research Council
Funding Amount
$102,576.00
Summary
I am a specialist clinical trials pharmacist focussed on the challenges associated with the conduct of medicinal trials in children. My intention is to collect evidence to determine the best strategies for improving the quantity, quality and relevance of clinical trials in children. This will help to ensure safe and effective age-appropriate drug therapies for children and improve the health outcomes of our children.